• 1
    Bukkapatnam R, Pow-Sang JM. Radical prostatectomy in the management of clinically localized prostate cancer. Cancer Control 2001; 8: 496502.
  • 2
    Tewari A. Management of clinically localized prostate cancer: pathologic processing to robotic prostatectomy. Rev Urol 2003; 5( Suppl 6): S3339.
  • 3
    Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996; 20: 286292.
  • 4
    Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167: 528534.
  • 5
    True LD. Surgical pathology examination of the prostate gland. Practice survey by American Society of Clinical Pathologists. Am J Clin Pathol 1994; 102: 572579.
  • 6
    Leibovich BC, Engen DE, Patterson DE, et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 2000; 163: 11781182.
  • 7
    Davis BJ, Pisansky TM, Leibovich BC. Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer. Curr Opin Urol 2003; 13: 117122.
  • 8
    Cohen MB, Soloway MS, Murphy WM. Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol 1994; 101: 250252.
  • 9
    Hall GS, Kramer CE, Epstein JI. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 1992; 16: 315324.
  • 10
    Jhavar SG, Fisher C, Jackson A, et al. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol 2005; 58: 504508.
  • 11
    Shah V, Pohida T, Turkbey B, et al. A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum 2009; 80: 104301.
  • 12
    Epstein JI, Amin M, Boccon-Gibod L, et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005: 3463.
  • 13
    McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992; 23: 258266.
  • 14
    Madabhushi A, Feldman MD, Metaxas DN, Tomaszeweski J, Chute D. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI. IEEE Trans Med Imaging 2005; 24: 16111625.
  • 15
    Zhan Y, Ou Y, Feldman M, Tomaszeweski J, Davatzikos C, Shen D. Registering histologic and MR images of prostate for image-based cancer detection. Acad Radiol 2007; 14: 13671381.
  • 16
    Xu J, Humphrey PA, Kibel AS, et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 2009; 61: 842850.
  • 17
    Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989; 172: 131137.
  • 18
    Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009; 30: 327334.
  • 19
    Swindle P, McCredie S, Russell P, et al. Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiology 2003; 228: 144151.